Table 2.
The KEGG pathway enrichment analysis.
| Gene name | Description | log2 Fold Change | Corrected p-value |
|---|---|---|---|
| Vitamin B6 metabolism | 4.54×10−4 | ||
| SNO3 | putative pyridoxal 5′-phosphate synthase | +1.01 | 1.08×10−5 |
| SNZ2 | GMP synthase activity | +1.46 | 3.15×10−40 |
| SNZ3 | Pyridoxal-5′-phosphate synthase | +1.48 | 1.34×10−28 |
| SNO2 | putative pyridoxal 5′-phosphate synthase | +1.75 | 2.67×10−40 |
| Thiamine metabolism | 8.15×10 | ||
| THI80 | thiamine diphosphokinase activity | +1.23 | 4.34×10−20 |
| THI21 | phosphomethylpyrimidine kinase activity | +1.54 | 7.4×10−18 |
| THI5 | Protein involved in synthesis of the thiamine precursor HMP | +1.08 | 1.39×10−4 |
| THI6 | thiamine-phosphate diphosphorylase activity | +1.21 | 9.36×10−18 |
| THI20 | phosphomethylpyrimidine kinase activity | +1.14 | 2.12×10−13 |
| THI22 | hydroxymethylpyrimidine phosphate kinases | +1.39 | 1.51×10−15 |
| THI72 | Transporter of thiamine or related compound | +1.12 | 5.67×10−10 |
| Arginine and proline metabolism | 6.43×10 | ||
| CAR1 | arginase | −2.10 | 2.28×10−32 |
| CAR2 | L-ornithine transaminase | +1.04 | 4.91×10−8 |
| PUT2 | δ−1-pyrroline-5-carboxylate dehydrogenase | −1.00 | 1.44×10−10 |
| PUT4 | Proline permease | −5.40 | 1.72×10−147 |
| PRO2 | γ-glutamyl phosphate reductase | −1.26 | 3.12×10−17 |
| GAP1 | Amino acid permease | −2.09 | 3.23×10−18 |
| SPE1 | Ornithine decarboxylase | −1.23 | 3.73×10−15 |
| Aminoacyl-tRNA biosynthesis | 5.09×10 | ||
| MSE1 | glutamate-tRNA ligase activity | +1.84 | 5.04×10−50 |
| MSW1 | tryptophan-tRNA ligase activity | +1.38 | 1.34×10−32 |
| MSM1 | methionine-tRNA ligase activity | +1.69 | 6.71×10−32 |
| MSF1 | phenylalanine-tRNA ligase activity | +1.60 | 1.76×10−30 |
| MSD1 | aminoacyl-tRNA ligase activity | +1.34 | 9.97×10−28 |
| AIM10 | proline-tRNA ligase activity | +1.42 | 3.10×10−25 |
| HER2 | glutaminyl-tRNA synthase activity | +1.12 | 3.00×10−17 |
| DIA4 | serine-tRNA ligase activity | +1.56 | 8.10×10−17 |
| TYS1 | tyrosine-tRNA ligase activity | −1.42 | 8.10×10−17 |
| KRS1 | lysine-tRNA ligase activity | −1.34 | 5.02×10−9 |
| CDC60 | leucine-tRNA ligase activity | −1.42 | 5.11×10−9 |
| THS1 | threonine-tRNA ligase activity | −1.20 | 6.05×10−9 |
| DPS1 | aspartate-tRNA ligase activity | −1.15 | 1.05×10−8 |
| DED81 | asparagine-tRNA ligase activity | −1.20 | 1.17×10−8 |
| ALA1 | alanine-tRNA ligase activity | −1.19 | 6.36×10−8 |
| FRS1 | phenylalanine-tRNA ligase activity | −1.01 | 4.96×10−7 |
| GLN4 | glutamine-tRNA ligase activity | −1.03 | 9.35×10−5 |
| Starch and sucrose metabolism | 4.56×10 | ||
| GSC2 | 1,3-beta-D-glucan synthase activity | +1.89 | 1.43×10−9 |
| DSE4 | glucan endo-1,4-beta-glucanase activity | +1.36 | 8.55×10−21 |
| Steroid biosynthesis | 1.48×10 | ||
| ERG26 | C-3 sterol dehydrogenase | +1.14 | 1.55×10−11 |
| ERG5 | oxidoreductase activity | +1.26 | 7.52×10−8 |
| ERG3 | oxidoreductase activity | +1.25 | 2.11×10−7 |
| ERG4 | oxidoreductase activity | +2.13 | 6.11×10−23 |
| ERG28 | ergosterol biosynthesis | +1.77 | 2.81×10−10 |
The column of “log2 Fold Change” represents the base-two logarithm value of the fold change of the gene expression; “+” means up-regulated genes; “−” means down-regulated genes. Hypergeometric test was used for statistical analysis. The p-values have been corrected for multiple testing by the Benjamini and Hochberg adjustment method. The corrected p value <0.05 plus the absolute log2 Fold Change value >1 were considered statistically significant.